CA
PAHC icon

Clearstead Advisors’s Phibro Animal Health PAHC Stock Holding History

Clearstead Advisors’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$126 Buy
+4
New +$169 ﹤0.01% 3308

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
HAI
Hennessy Advisors Inc Novato, California $3.13B AUM 77.26% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
CCMINC
Cardinal Capital Management Inc (North Carolina) Raleigh, North Carolina $826M AUM 32.06% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Clearstead Advisors's PAHC Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Phibro Animal Health (PAHC) in Q2 2026: 4 shares worth $126. The stake represents ﹤0.01% of the portfolio and ranks #3308 among its holdings.

72 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Clearstead Advisors held 4 shares of Phibro Animal Health worth $126 as of Q2 2026.
  • Phibro Animal Health was a new Clearstead Advisors position in Q2 2026.
  • Phibro Animal Health made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #3308 holding.
  • 72 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.